Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Equivalent dose rate at 1m of patients with known or suspected neuroendocrine tumor exiting a nuclear medicine department after 68Ga-DOTATOC, 18F-FDOPA or 18F-FDG PET/CT, or 111In-pentetreotide or 123I-mIBG SPECT/CT

Jules Zhang-Yin, Anne-Sophie Dirand, Myriam Sasanelli, Gwenaelle Corrégé, Aude Peudon, Thierry Kiffel, Valérie Nataf, Jérôme Clerc, Françoise Montravers and Jean-Noël Talbot
Journal of Nuclear Medicine February 2017, jnumed.116.187138; DOI: https://doi.org/10.2967/jnumed.116.187138
Jules Zhang-Yin
1 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Sophie Dirand
1 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myriam Sasanelli
2 Department of Nuclear Medicine, Hôpital Cochin, AP-HP, Paris, France, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gwenaelle Corrégé
1 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aude Peudon
2 Department of Nuclear Medicine, Hôpital Cochin, AP-HP, Paris, France, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Kiffel
3 Université Pierre et Marie Curie (UPMC), Paris, France., France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valérie Nataf
4 Radiopharmacy, Hôpital Tenon, AP-HP, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérôme Clerc
5 Department of Nuclear Medicine, Hôpital Cochin, AP-HP, Paris, France., France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Françoise Montravers
6 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France., France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Noël Talbot
6 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France., France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.116.187138
DOI 
https://doi.org/10.2967/jnumed.116.187138
PubMed 
28209907

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online February 16, 2017.

Article Versions

  • You are currently viewing a previous version of this article (February 16, 2017 - 07:39).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2017 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Jules Zhang-Yin1,
  2. Anne-Sophie Dirand1,
  3. Myriam Sasanelli2,
  4. Gwenaelle Corrégé1,
  5. Aude Peudon2,
  6. Thierry Kiffel3,
  7. Valérie Nataf4,
  8. Jérôme Clerc5,
  9. Françoise Montravers6 and
  10. Jean-Noël Talbot6
  1. 1 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France, France;
  2. 2 Department of Nuclear Medicine, Hôpital Cochin, AP-HP, Paris, France, France;
  3. 3 Université Pierre et Marie Curie (UPMC), Paris, France., France;
  4. 4 Radiopharmacy, Hôpital Tenon, AP-HP, Paris, France;
  5. 5 Department of Nuclear Medicine, Hôpital Cochin, AP-HP, Paris, France., France;
  6. 6 Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France., France
  1. For correspondence or reprints contact: Jules Zhang-Yin, Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France, 4 rue de la chine, Paris, France 75020, France. E-mail: juleszhangyin@gmail.com

Statistics from Altmetric.com

Cited By...

  • 9 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • OCCUPATIONAL RADIATION DOSE TO NUCLEAR MEDICINE STAFF DUE TO TC99M, F18-FDG PET AND THERAPEUTIC I-131 BASED EXAMINATIONS
    Mohamed Fathy, Magdy M Khalil, Wael M Elshemey, Haitham S Mohamed
    Radiation Protection Dosimetry 2019 186 4
  • Environmental radiation dose rate arising from patients of PET/CT
    O. Günay, E. Abamor
    International Journal of Environmental Science and Technology 2019 16 9
  • EFFECTIVE RADIATION DOSE TO STAFF MEMBERS DUE TO MYOCARDIAL PERFUSION SPECT IMAGING: TRACKING THE EXPOSURE FROM PREPARATION TO PATIENT RELEASE
    Shaban Alramlawy, Magdy Mohamed Khalil
    Radiation Protection Dosimetry 2018 182 3
  • IPEM topical report: current molecular radiotherapy service provision and guidance on the implications of setting up a dosimetry service
    Allison J Craig, Bruno Rojas, Jill L Wevrett, Elaine Hamer, Andrew Fenwick, Rebecca Gregory
    Physics in Medicine & Biology 2020 65 24
  • Equivalent dose rate from patients after whole-body FDG-PET/CT
    G. Bera, M. Soret, J.-A. Maisonobe, A. Giron, J.-M. Garnier, M.-O. Habert, A. Kas
    Médecine Nucléaire 2018 42 1
  • External Exposure to Veterinary Staff and Pet Owners from <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) Positron Emission Tomography
    Nattawipa Suwannasaeng, Takehiko Kakizaki, Seiichi Wada, Masahiro Natsuhori
    RADIOISOTOPES 2022 71 2
  • Radiation dose measurement on bone scintigraphy and planning clinical management
    Mucize Sarihan, Evrim Abamor
    Open Physics 2022 20 1
  • Re-Evaluation of Patient-Sourced Radiation Doses in PET/CT
    Ahmet Murat Şenışık, Handan Tanyıldızı Kökkülünk, Mahmut Yüksel
    Current Radiopharmaceuticals 2023 16 2
  • Reducing Radiation Exposure from PET Patients
    Shorouk F. Dannoon, Saud Alenezi, Naheel Alnafisi, Samar Almutairi, Fatma Dashti, Medhat M. Osman, Abdelhamid Elgazzar
    Journal of Nuclear Medicine Technology 2022 50 3

Article usage

Article usage: February 2017 to April 2025

AbstractFullPdf
Feb 2017364043
Mar 2017316017
Apr 201721804
May 2017248013
Jun 2017177013
Jul 2017158012
Aug 201712151382
Sep 2017202612
Oct 201715212
Nov 201711958
Dec 20177918
Jan 20186003
Feb 201854216
Mar 20183967
Apr 20183979
May 201845612
Jun 2018331513
Jul 20182363
Aug 20182665
Sep 2018231211
Oct 20181947
Nov 20181289
Dec 2018191328
Jan 2019331320
Feb 2019201215
Mar 201921723
Apr 201916921
May 201926210
Jun 201916611
Jul 201910721
Aug 201913314
Sep 20191127
Oct 201928711
Nov 201912517
Dec 20191056
Jan 202018621
Feb 20201234
Mar 2020211013
Apr 20201637
May 202022614
Jun 20201027
Jul 20201337
Aug 20201739
Sep 20201226
Oct 202019214
Nov 202024514
Dec 202017512
Jan 2021579
Feb 202151117
Mar 202181110
Apr 2021121814
May 2021151819
Jun 20219108
Jul 20216913
Aug 202161113
Sep 2021999
Oct 202161416
Nov 2021131027
Dec 202192511
Jan 20225199
Feb 2022141311
Mar 2022121413
Apr 2022586
May 202251111
Jun 2022879
Jul 20225238
Aug 202291410
Sep 20223248
Oct 20222610
Nov 2022392
Dec 2022459
Jan 202311138
Feb 2023774
Mar 202331312
Apr 20232118
May 2023265
Jun 2023764
Jul 202301412
Aug 2023947
Sep 2023353
Oct 202391111
Nov 202313414
Dec 20236224
Jan 20248812
Feb 20248512
Mar 20247332
Apr 202431415
May 202433210
Jun 202442512
Jul 202481912
Aug 202461311
Sep 20242135
Oct 202491916
Nov 20247179
Dec 20242139
Jan 202531212
Feb 20258558
Mar 202582310
Apr 2025183539
Next
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Equivalent dose rate at 1m of patients with known or suspected neuroendocrine tumor exiting a nuclear medicine department after 68Ga-DOTATOC, 18F-FDOPA or 18F-FDG PET/CT, or 111In-pentetreotide or 123I-mIBG SPECT/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Equivalent dose rate at 1m of patients with known or suspected neuroendocrine tumor exiting a nuclear medicine department after 68Ga-DOTATOC, 18F-FDOPA or 18F-FDG PET/CT, or 111In-pentetreotide or 123I-mIBG SPECT/CT
Jules Zhang-Yin, Anne-Sophie Dirand, Myriam Sasanelli, Gwenaelle Corrégé, Aude Peudon, Thierry Kiffel, Valérie Nataf, Jérôme Clerc, Françoise Montravers, Jean-Noël Talbot
Journal of Nuclear Medicine Feb 2017, jnumed.116.187138; DOI: 10.2967/jnumed.116.187138

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Equivalent dose rate at 1m of patients with known or suspected neuroendocrine tumor exiting a nuclear medicine department after 68Ga-DOTATOC, 18F-FDOPA or 18F-FDG PET/CT, or 111In-pentetreotide or 123I-mIBG SPECT/CT
Jules Zhang-Yin, Anne-Sophie Dirand, Myriam Sasanelli, Gwenaelle Corrégé, Aude Peudon, Thierry Kiffel, Valérie Nataf, Jérôme Clerc, Françoise Montravers, Jean-Noël Talbot
Journal of Nuclear Medicine Feb 2017, jnumed.116.187138; DOI: 10.2967/jnumed.116.187138
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Reducing Radiation Exposure from PET Patients
  • Google Scholar

Similar Articles

Keywords

  • neuroendocrine
  • PET/CT
  • radiation safety
  • Neuro Endocrine Tumors (NET)
  • Somatostatin receptor based PET/CT
  • Somatostatin receptor based SPECT/CT
  • dose rate
  • Radiation Protection
SNMMI

© 2025 SNMMI

Powered by HighWire